A treatment reengagement intervention for syringe exchangers

Journal of Substance Abuse Treatment

Volumn 41, Issue 4, 2011, Pages 415-421

  Kidorf, Michael ^a   King, Van L ^a   Peirce, Jessica ^a   Kolodner, Ken ^a   Brooner, Robert K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Harm reduction; Opioid dependence; Public health; Substance abuse treatment; Syringe exchange; Treatment reengagement;

Indexed keywords

METHADONE;

ADULT; ARTICLE; FEMALE; HEALTH PROGRAM; HUMAN; ILLNESS BEHAVIOR; INTERVENTION STUDY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOTIVATION; OPIATE ADDICTION; PATIENT PARTICIPATION; PATIENT REFERRAL; PRIORITY JOURNAL; SYRINGE; TREATMENT REFUSAL;

ADULT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MOTIVATION; NEEDLE-EXCHANGE PROGRAMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, GROUP; RANDOM ALLOCATION; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; SYRINGES; TIME FACTORS;

EID: 82455199231     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.06.008     Document Type: Article

References (34)

1. Booth R., Kwiatkowski C., Iguchi M., Pinto F., John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Reports 1998, 113:116-128.
2. Booth R.E., Corsi K.F., Mikulich S.K. Improving entry to methadone maintenance among out-of-treatment injection drug users. Journal of Substance Abuse Treatment 2003, 24:305-311.
3. Booth R.E., Corsi K.F., Mikulich-Gilbertson S.K. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug and Alcohol Dependence 2004, 74:177-185.
4. Brooner, R., Kidorf, M., King, V., Beilenson, P., Svikis, D., & Vlahov, D. (1998). Drug abuse treatment success among needle exchange participants. Public Health Reports, 113, 129, 139.
5. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 1997, 54:71-80.
6. Carey K.B., Purnine D.M., Maisto S.A., Carey M.P. Assessing readiness to change substance abuse: A critical review of instruments. Clinical Psychology: Science and Practice 1999, 6:245-266.
7. Carroll K.M., Ball S.A., Nich C., Martino S., Frankforter T.L., Farentinos C., et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 2006, 81:301-312.
8. Des Jarlais D.C., Marmor M., Paone D., Titus S., Shi Q., Perlis T., et al. HIV incidence among injecting drug users in New York City syringe exchange programmes. Lancet 1996, 348:987-991.
9. Ettner S.L., Huang D., Evans E., Ash D.R., Hardy M., Jorabchi M., et al. Benefit-cost in the California treatment outcome project: Does substance abuse treatment pay for itself. Heath Services Research 2005, 41:192-213.
10. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis disorders-Patient edition (SCID-I/P, Version 2.0) 1995, Biometrics Research, New York State Psychiatric Institute, New York.
11. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
12. Friedmann P.D., Lemon S.C., Stein M.D. Transportation and retention in outpatient drug abuse treatment programs. Journal of Substance Abuse Treatment 2001, 21:97-103.
13. Gowing L., Farrell M., Bronemann R., Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Library 2007, 3:1-58.
14. Grau L.E., Bluthenthal R.N., Marshall P., Singer M., Heimer R. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS and Behavior 2005, 9:495-504.
15. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment?. Journal of Substance Abuse Treatment 1998, 15:183-191.
16. Huo D., Ouellet L.J. Needle exchange and injection-related risk behaviors in Chicago: A longitudinal study. Journal of Acquired Immune Deficiency Syndrome 2007, 45:108-114.
17. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence 2004, 74:115-122.
18. Kidorf M., King V.L. Expanding the public health benefits of syringe exchange programs. Canadian Journal of Psychiatry 2008, 53:487-495.
19. Kidorf M., King V.L., Neufeld K., Pierce J., Kolodner K., Brooner R.K. Improving substance abuse treatment enrollment in community syringe exchangers. Addiction 2009, 104:786-795.
20. McConnaughy E.A., DiClemente C.C., Prochaska J.O., Velicer W. Stages of change in psychotherapy: A follow-up report. Psychotherapy Theory and Research Practice 1989, 26:494-503.
21. McLellan A.T., Cacciola J.C., Alterman A.I., Rikoon S.H., Carise D. The Addiction Severity Index at 25: Origins, contributions and transitions. The American Journal of Addictions 2006, 15:113-124.
22. McLellan A.T., Kushner H., Metzger D., Peters R., Smith L., Grisson G., et al. The fifth edition of the Addiction Severity Index: Historical critique and normative data. Journal of Substance Abuse Treatment 1992, 9:199-213.
23. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 2000, 284:1689-1695.
24. Miller W.R., Rollnick S. Motivational interviewing: Preparing people for change 2002, The Guilford Press, New York. 2nd ed.
25. Neufeld K., King V., Peirce J., Kolodner K., Brooner R., Kidorf M. A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals. Drug and Alcohol Dependence 2008, 97:122-129.
26. Matching alcoholism treatment to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol 1997, 58:7-29. Project MATCH Research Group.
27. Simpson D.D., Joe G.W., Rowan-Szal G.A. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence 1997, 47:227-235.
28. Sorensen J.L., Masson C.L., Delucchi K., Sporer K., Barnett P.G., Mitsuishi F., et al. Randomized trial of drug abuse treatment-linkage strategies. Journal of Consulting and Clinical Psychology 2005, 73:1026-1035.
29. Strathdee S.A., Ricketts E.P., Huettner S., Cornelius L., Bishai D., Havens J.R., et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence 2006, 83:225-232.
30. Substance Abuse and Mental Health Services Administration (SAMHSA) Treatment Episode Data Set (TEDS). Highlights - 2007 2009, National admissions to substance abuse treatment services, DASIS series: S-45, Rockville, MD, (DHHS Publication No. (SMA) 09-4360).
31. Van Den Berg C., Smit C., Van Brussel G., Coutinho R., Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007, 102:1454-1462.
32. Villafranca S.W., McKellar J.D., Trafton J.A., Humphreys K. Predictors of retention in methadone programs: A signal detection analysis. Drug and Alcohol Dependence 2006, 83:218-224.
33. Wodak A., Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use and Misuse 2006, 41:777-813.
34. Zhang Z., Friedmann P.D., Gerstein D.R. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003, 98:673-684.